Rodríguez Garzotto, Analia <br/><br/>
Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Oct 2016 
 - 105 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-016-0824-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Cell Adhesion Molecules--blood<br/>E-Selectin--blood<br/>Female<br/>Fibroblast Growth Factor 2--blood<br/>Humans<br/>Leukocytes, Mononuclear--metabolism<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Neovascularization, Pathologic--blood<br/>Transcriptome<br/>Vascular Endothelial Growth Factor A--blood